Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 7 | 2019 | 90 | 2.300 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2023 | 99 | 1.190 |
Why?
|
| Interleukins | 4 | 2019 | 108 | 1.140 |
Why?
|
| Virus Diseases | 3 | 2017 | 38 | 1.070 |
Why?
|
| Immunologic Memory | 6 | 2024 | 58 | 0.860 |
Why?
|
| Acetylcholine | 1 | 2023 | 73 | 0.840 |
Why?
|
| Eosinophils | 1 | 2022 | 6 | 0.800 |
Why?
|
| Choline O-Acetyltransferase | 2 | 2019 | 8 | 0.780 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2019 | 6 | 0.780 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2019 | 37 | 0.610 |
Why?
|
| Costimulatory and Inhibitory T-Cell Receptors | 1 | 2017 | 2 | 0.590 |
Why?
|
| CTLA-4 Antigen | 1 | 2017 | 9 | 0.580 |
Why?
|
| Hepatitis B virus | 1 | 2017 | 16 | 0.580 |
Why?
|
| Hepacivirus | 1 | 2017 | 46 | 0.570 |
Why?
|
| HIV-1 | 1 | 2017 | 54 | 0.570 |
Why?
|
| Immunotherapy | 1 | 2017 | 134 | 0.520 |
Why?
|
| Obesity | 1 | 2022 | 647 | 0.520 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 316 | 0.500 |
Why?
|
| Lymphocyte Activation | 6 | 2019 | 203 | 0.490 |
Why?
|
| DNA Viruses | 1 | 2013 | 3 | 0.420 |
Why?
|
| RNA Viruses | 1 | 2013 | 5 | 0.420 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 57 | 0.420 |
Why?
|
| Animals | 18 | 2024 | 9954 | 0.410 |
Why?
|
| T-Lymphocytes | 5 | 2019 | 274 | 0.380 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 1474 | 0.370 |
Why?
|
| Cytokines | 2 | 2013 | 437 | 0.370 |
Why?
|
| Interleukin-2 | 1 | 2011 | 33 | 0.370 |
Why?
|
| Immunity, Innate | 3 | 2023 | 204 | 0.350 |
Why?
|
| Mice | 12 | 2024 | 4402 | 0.340 |
Why?
|
| Cell Movement | 3 | 2019 | 353 | 0.290 |
Why?
|
| Inflammation | 3 | 2018 | 598 | 0.280 |
Why?
|
| Glutamate-Cysteine Ligase | 2 | 2017 | 25 | 0.260 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2019 | 6 | 0.250 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 487 | 0.250 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 64 | 0.240 |
Why?
|
| Germinal Center | 1 | 2024 | 20 | 0.230 |
Why?
|
| Receptors, CXCR4 | 1 | 2024 | 27 | 0.230 |
Why?
|
| Mice, Knockout | 6 | 2019 | 781 | 0.210 |
Why?
|
| Acute Disease | 3 | 2013 | 156 | 0.210 |
Why?
|
| Humans | 9 | 2024 | 26856 | 0.200 |
Why?
|
| Adipose Tissue, White | 1 | 2022 | 16 | 0.200 |
Why?
|
| Bacterial Toxins | 1 | 2024 | 265 | 0.180 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 276 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 474 | 0.170 |
Why?
|
| Glutathione | 2 | 2017 | 68 | 0.170 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 29 | 0.160 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 399 | 0.150 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 25 | 0.150 |
Why?
|
| Sensory Receptor Cells | 1 | 2018 | 14 | 0.150 |
Why?
|
| Vasodilation | 1 | 2019 | 114 | 0.150 |
Why?
|
| Monocytes | 1 | 2019 | 132 | 0.150 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 1 | 2017 | 6 | 0.150 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 128 | 0.150 |
Why?
|
| Antibodies | 1 | 2018 | 124 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2019 | 245 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2017 | 134 | 0.140 |
Why?
|
| Ephrin-B3 | 1 | 2016 | 1 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 11 | 0.130 |
Why?
|
| Hemostasis | 1 | 2016 | 47 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 123 | 0.130 |
Why?
|
| Proteolysis | 1 | 2016 | 55 | 0.130 |
Why?
|
| Lysosomes | 1 | 2016 | 54 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 80 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 69 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 367 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 54 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2019 | 466 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 56 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2016 | 351 | 0.120 |
Why?
|
| Intestines | 1 | 2016 | 117 | 0.120 |
Why?
|
| Chronic Disease | 3 | 2010 | 264 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 21 | 0.120 |
Why?
|
| Antigen Presentation | 2 | 2019 | 78 | 0.110 |
Why?
|
| Cell Differentiation | 1 | 2016 | 395 | 0.110 |
Why?
|
| Th1-Th2 Balance | 1 | 2013 | 3 | 0.110 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2013 | 5 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 23 | 0.110 |
Why?
|
| Antioxidants | 1 | 2015 | 222 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 36 | 0.100 |
Why?
|
| Female | 5 | 2024 | 14462 | 0.100 |
Why?
|
| Carcinogenesis | 3 | 2019 | 79 | 0.100 |
Why?
|
| Helminthiasis | 1 | 2010 | 4 | 0.090 |
Why?
|
| Cross-Priming | 1 | 2010 | 5 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2010 | 63 | 0.090 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 31 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2010 | 102 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 441 | 0.080 |
Why?
|
| Male | 3 | 2019 | 12866 | 0.080 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 11 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 41 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2007 | 22 | 0.070 |
Why?
|
| Skin | 1 | 2008 | 140 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2017 | 40 | 0.070 |
Why?
|
| Autoantigens | 1 | 2007 | 212 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2007 | 162 | 0.070 |
Why?
|
| Apoptosis | 1 | 2008 | 737 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2018 | 969 | 0.060 |
Why?
|
| Chemokine CXCL12 | 1 | 2024 | 9 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2024 | 75 | 0.060 |
Why?
|
| Clostridium Infections | 1 | 2024 | 66 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 266 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2019 | 277 | 0.040 |
Why?
|
| Neuroimmunomodulation | 1 | 2018 | 5 | 0.040 |
Why?
|
| Antigens | 1 | 2018 | 66 | 0.040 |
Why?
|
| Immune Tolerance | 2 | 2008 | 49 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 46 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 144 | 0.040 |
Why?
|
| Immunization | 1 | 2018 | 118 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 13 | 0.040 |
Why?
|
| Glutamine | 1 | 2017 | 32 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 9 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 82 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 121 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 45 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 68 | 0.030 |
Why?
|
| Paneth Cells | 1 | 2016 | 8 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2016 | 9 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2016 | 24 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 25 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 49 | 0.030 |
Why?
|
| Endocytosis | 1 | 2016 | 81 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2017 | 176 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2016 | 173 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 277 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 347 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1259 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 282 | 0.030 |
Why?
|
| Thioredoxins | 1 | 2015 | 26 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 117 | 0.030 |
Why?
|
| Models, Biological | 1 | 2016 | 446 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 664 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 770 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 820 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 1339 | 0.020 |
Why?
|
| Thy-1 Antigens | 1 | 2010 | 3 | 0.020 |
Why?
|
| Virus Activation | 1 | 2010 | 9 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 18 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 88 | 0.020 |
Why?
|
| Stem Cells | 1 | 2010 | 113 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 239 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 393 | 0.020 |
Why?
|
| Langerhans Cells | 1 | 2008 | 3 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 33 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2008 | 32 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 168 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 151 | 0.020 |
Why?
|
| Peptides | 1 | 2007 | 280 | 0.020 |
Why?
|